Mark Rothko's Former Studio Returns to Market for $9.5 Million USD
Ahistoric carriage housein New York City once used byMark Rothkoas his studio is now on the market for $9.5 million USD. Originally built in 1884 by architect William Schickel, the red-brick property situated on the Upper East Side has evolved from a horse stable into a five-bedroom residence complete with arched windows, a wood-burning fireplace, elevator, rooftop garden, wine cellar and a traditional tea room with Shoji screens.
But what sets the 4,700-square-foot home apart is its cultural legacy. Rothko painted here in the 1960s, using the skylit upper floor to create the immersive works now housed in Houston's Rothko Chapel. He even covered the skylight with a parachute to control the light while working. In the 1950s, the space briefly operated as a music studio where Elvis Presley recorded part ofLove Me Tender.
Today, the residence is co-owned by a private family and the Urasenke Tea Ceremony Society, a Japanese nonprofit dedicated to preserving traditional tea culture. The society operates part of the home as a tea study center and maintains the ceremonial space. The listing includes only the family's share, but a clause allows for a full buyout in 12 years, offering a rare chance to eventually own the full property.
The building is held under a 50-year tenants-in-common agreement, with a required sale in 12 years that includes the third floor, offering potential for strong future returns. 'The property will be worth a lot more at that time,' listing broker Jeremy Stein told theNew York Post.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Stocks Are Soaring — But the Dollar's Sinking. What Smart Investors Are Doing Right Now
The U.S. Dollar is weakening, and this could affect your portfolio. While the S&P 500 just hit fresh highs, the fact that it comes with international currencies getting stronger may be of concern to U.S. investors. Trending Now: Check Out: But smart investors are leveraging a different investment approach that can protect against a sharp downturn in U.S. dollar value. GOBankingRates reviews what investors can do to make sure they can keep their portfolios in shape. Why Is the U.S. Dollar Losing Value? In short, the U.S. dollar has been losing value to other strong global currencies (such as the Euro) due to Trump tariffs. With an increase in tariffs on imported goods to the U.S., foreign investors have backed off on purchasing U.S. Treasuries. Even with strong yields, the U.S. recently saw a drop in its overall credit rating, stoking fears of the ability for the U.S. to pay interest on the issued Treasuries, as reported by NBC News. Combined with potential inflation and economic growth slowing due to high tariffs, investors are pivoting away from U.S. Treasury investments, causing the dollar to lose over 10% of its value compared to other global currencies. With the dollar losing value, this can cause inflationary pressures and may indicate lower-than-expected returns in U.S. equity markets going forward. Consider This: What Investments Help Protect Your Portfolio? If a declining U.S. dollar points to lower equity returns, what should investors be doing to protect their portfolios? First, it's important to note that while the U.S. dollar is weakening in 2025, historically it has held its value globally, and is stronger today than it was just a decade ago (in many countries). A short-term drop in the value of the U.S. Dollar doesn't mean it's going to be weak forever, and making long-term investment decisions based on short term drops in value may not be the best approach. That being said, investors that do expect this trend to continue, and expect lower returns on U.S. equities in the coming months (or even years), can hedge against a weak dollar in several ways. Foreign equities: While high tariffs have hurt U.S. businesses and the U.S. dollar, foreign equities are still seeing strong growth. In fact, ex-U.S. equity indices have outperformed U.S. indices in 2025 so far by nearly 10%. Investing globally instead of in just U.S.-based companies can help you protect from slow growth in the U.S. Commodities: Commodities (such as agriculture, metals and energy stocks) can help hedge against a weaker U.S. dollar. As the dollar weekend, commodities become 'cheaper' to foreign investors, which could increase demand. This can push the price higher, even as the U.S. dollar drops in value. Gold: Gold is a timeless 'safe haven' asset that helps preserve purchasing power over time. In uncertain and inflationary markets, Gold tends to rise in value. As the U.S. dollar weakens, Gold could continue to grow in value due to increased demand for assets that hold their value, independent of fiat currencies. Upsides of a Weaker U.S. Dollar Hedging your portfolio against a weakening U.S. dollar can help protect your investments, but there may also be a few upsides to a devaluing of the U.S. Dollar globally. As the U.S. Dollar weakens against foreign currencies (like the Euro), this effectively lowers the price of U.S. goods to foreign inventors. This may increase demand for U.S. goods, which can help boost the economy. Plus, owning U.S. stocks at today's dollar prices can be a good investment. As foreign investors can purchase more U.S. stocks for less of their local currency, this can push prices of U.S. stocks up. And if you own an inflation hedge asset like real estate (with a mortgage), you're paying down your future home payments with less valuable U.S. Dollars. This is effectively a discount on your mortgage payments by the decline in value of U.S. Dollars each year. More From GOBankingRates How Much Money Is Needed To Be Considered Middle Class in Your State? This article originally appeared on Stocks Are Soaring — But the Dollar's Sinking. What Smart Investors Are Doing Right Now Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
UPI
2 hours ago
- UPI
Mitsubishi Heavy to build new Australian naval fleet
Japan's Mitsubishi Heavy Industries will build Mogami-class frigates, like the one pictured here, for Australia's naval fleet. File Photo by Keizo Mori/UPI | License Photo Aug. 5 (UPI) -- The Mitsubishi Heavy Industries Group announced Tuesday that the Australian government has chosen it to build a new fleet of warships for the nation's navy. The Japanese shipbuilder said in a press release that Australia selected the upgraded version of Mitsubishi's 4,800-ton type Mogami-class frigate for its new general-purpose frigates. "We believe that the decision made by the Australian government is based on its evaluation of our frigate's proven performance, reliability, technology, and capabilities, multi-functionality suitable for various roles including anti-submarine, anti-aircraft, and anti-surface warfare, as well as reduced manpower requirements compared to conventional frigates, and scalability to easily enhance capabilities in the future," Mitsubishi said. The first three frigates are slated to be built in Japan, under a contract worth more than $6.4 billion, but the rest of the 11-vessel order is expected to be constructed in Australia. Australian Deputy Prime Minister and Defense Minister Richard Marles said during a press conference that the Mogami-class frigate was chosen due to its stealth capabilities and can operate with nearly half the crew currently aboard the Australian Navy's Anzac-class frigates, which have been in use since the end of World War II. "It's all part of our $55 billion investment in the Navy's surface combatant fleet," Australian Defense Industry Minister Pat Conroy posted to X Tuesday. "And it means tens of thousands of well-paid, highly skilled jobs here at home." "It's a decision months ahead of schedule, and a decision that means our first frigate will be delivered in 2029," Conroy also posted.
Business Wire
3 hours ago
- Business Wire
Lura Health Announces Strategic Investment and Business Partnership with SCO Group to Advance Intraoral Health Monitoring
NEWARK, N.J.--(BUSINESS WIRE)-- Lura Health (UCHU Biosensors, Inc., Head Office: Newark, New Jersey, USA; CEO: Daniel Weinstein), a U.S. health tech company, today announced that it has entered into an investment and business partnership with SCO Group (Head Office: Chiyoda-ku, Tokyo, Japan; Chairman and CEO: Yusuke Tamai), a leading company in Japan's dental technology sector. The goal of the partnership is to deploy Lura Health's intraoral sensor technology into clinical use in Asia and expand its applications globally. Lura Health is developing wearable microsensors that can be worn inside the mouth, either attached to dental appliances or bonded directly to a tooth, to collect real-time biometric data such as pH levels and metabolites in saliva. The company is pioneering a new healthcare model that aims to "visualize whole-body health from within the oral cavity." Background and Purpose of the Partnership Lura Health has created the world's first continuous intraoral salivary monitoring sensor and is targeting medical device approval from the U.S. Food and Drug Administration (FDA) by early 2027. Following regulatory approval, Lura plans to expand its reach into Asian markets, starting with Japan. SCO Group is the operator of "Pay Light X," an integrated dental clinic management platform in Japan that supports appointment booking, diagnosis, payment, and aftercare. By integrating its sensor technology with SCO Group's clinical infrastructure, Lura Health aims to establish a new model for preventive health care in Japan. Key Points of the Partnership Continuous Monitoring with Intraoral Sensors Lura's sensors allow real-time monitoring of oral conditions such as pH and other salivary parameters. These measurements have the potential to supplement or replace conventional lab-based diagnostics in the future. Deployment through SCO Group's Platform By integrating with SCO Group's "Pay Light X," Lura aims to deliver its technology seamlessly to clinicians and patients. Joint pilot projects with Japanese universities and research institutions are expected to begin this fall to generate clinical validation and user feedback. Applications Beyond Dentistry Future use cases for the technology extend into sports performance monitoring, eldercare, and wellness, positioning Lura's sensors as a core tool in comprehensive personal health management. Statement from Daniel Weinstein, CEO of Lura Health "We at Lura Health are honored to announce our investment and business partnership with SCO Group, a leader in digital transformation within the Japanese dental industry. This collaboration represents a major step forward in our mission to enable preventive and user-friendly health monitoring through the diagnostic power of saliva. Our vision aligns deeply with SCO Group's commitment to improving the well-being of individuals through technology. Together, we will combine our sensor innovations with their extensive healthcare network to create tangible societal impact. We look forward to deploying our sensors in real-world clinical settings and co-developing patient-centered products based on live feedback from users in Japan." Partner Statement: Yusuke Tamai, Chairman and CEO of SCO Group "We are very pleased to partner with Lura Health, whose groundbreaking intraoral biosensing technology embodies the future of preventive healthcare. At SCO Group, we have long championed the integration of health technology into daily life, and this partnership allows us to take that mission to the next level. The oral cavity is a gateway to the body's health, yet remains one of the least-monitored areas. By utilizing saliva—a highly accessible source of biological data—we aim to convert invisible health risks into visible insights. Combined with our Pay Light X platform, we intend to build a comprehensive preventive care model that spans diagnosis, treatment, and everyday living." About Lura Health Lura Health is a U.S.-based medical device company developing intraoral microsensors that enable noninvasive, continuous monitoring of health biomarkers via saliva. Led by CEO Daniel Weinstein (Forbes 30 Under 30, Tufts University), the company specializes in microelectronics and biosignal processing and has drawn significant attention in fields such as oral health, diabetes, kidney disease, and therapeutic drug monitoring. LinkedIn:
